Key result
Moderate-to-severe depressive symptoms in T2DM patients were associated with poorer metabolic control, including 0.18% higher HbA1c levels (95% CI 0.12-0.24) compared to no depressive symptoms.
Why the study?
Patients with T2DM face an increased risk of depression and metabolic dysregulation, but the relationship between depression severity and metabolic dysregulation remains unclear.
Does the severity of depressive symptoms correlate with worse metabolic control in patients with T2DM?
Cohort
Does the severity of depressive symptoms correlate with worse metabolic control in patients with T2DM?
Mean Difference: 0.18 (95% CI 0.12–0.24)
Greater severity of depressive symptoms in T2DM patients is significantly associated with poorer glycemic, blood pressure, and lipid control, highlighting the need to address mental health in diabetes management.
No takes yet. Share an insight, caveat, or question.
Depression severity was associated with metabolic dysregulation in T2DM; leaves open whether screening or treatment alters CVD risk.
Yang et al. (2024) conducted a cohort in Type 2 diabetes mellitus (T2DM). Moderate-to-severe depressive symptoms vs. No depressive symptoms was evaluated on HbA1c levels (MD 0.18%, 95% CI 0.12, 0.24). Moderate-to-severe depressive symptoms in T2DM patients were associated with poorer metabolic control, including 0.18% higher HbA1c levels (95% CI 0.12-0.24) compared to no depressive symptoms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: